QR kȏd

Safety and Efficacy of Prophylactic Topical Steroid Administration for Enfortumab Vedotin–related Cutaneous Toxicity

Enfortumab vedotin (EV) is used to treat unresectable/metastatic urothelial carcinoma but often causes cutaneous toxicity (EVRCT) because of Nectin4 expression in the skin, which reduces patients’ quality of life and can lead to dose adjustments or discontinuation. We explored whether applying topic...

Cijeli opis

Spremljeno u:
Glavni autori: Yuki Kita, Takashi Nomura, Saeko Nakajima, Satoru Yonekura, Kaoru Murakami, Takayuki Sumiyoshi, Kimihiko Masui, Takayuki Goto, Ryoichi Saito, Kenji Kabashima, Takashi Kobayashi
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2024-12-01
Serija:European Urology Open Science
Teme:
Enfortumab vedotin
Cutaneous toxicity
Prophylactic topical steroid
Online pristup:http://www.sciencedirect.com/science/article/pii/S2666168324010863
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti